Sperm Freezing Before Gender-Affirming Hormone Therapy: What Trans Women and Non-Binary People Should Know

Guidelines recommend discussing fertility preservation before feminizing hormones start, and banking sperm beforehand is the established way to keep the option of a genetically related child. Here is what the guidelines, the evidence and the price lists say.

Key takeaways

• WPATH SOC8 (2022) and the Endocrine Society (2017) recommend discussing fertility preservation before gender-affirming hormones start, and UCSF Transgender Care’s 2016 guideline calls sperm freezing before hormone therapy the most successful fertility preservation option for trans women.
• Feminizing hormones impair sperm production. In 173 orchiectomy specimens from trans women who had taken hormones (Jindarak 2018), 11% showed normal spermatogenesis, and severity was not related to how long hormones had been taken.
• Production can return after pausing hormones, but slowly and with no guarantee. In a 2023 case series of nine trans women who stopped hormones (de Nie et al.), viable sperm was eventually found in all nine, one of them only by testicular sperm extraction, and four had at least one semen analysis within WHO reference values.
• After an orchiectomy there is no further sperm production; only sperm banked earlier, or sperm or tissue retrieved at the time of surgery, remains usable.
• Most clinics ask for 2 to 3 semen samples at least 2 days apart, and some accept a sample produced at home if it arrives within about 1 hour; US mail-in services let you collect at home and ship overnight.
• US examples (as of October 2026): Fairfax Cryobank charges $375 to process and freeze one unwashed specimen plus a $150 consultation and $140 blood panel, with storage at $530 a year per account; Legacy’s mail-in plan is $540 for one sample with one year of storage. Point of Pride’s Thrive Fund accepts requests of up to $2,500 (as of October 2026), and RESOLVE lists 22 states with some fertility preservation mandate.

Why timing matters: what feminizing hormones do to sperm production

Gender-affirming hormone therapy for trans women and transfeminine non-binary people usually combines estrogen with an anti-androgen, or in some settings a GnRH agonist. All of these suppress the testosterone signal that the testes need to make sperm. WPATH SOC8 puts it plainly: anti-androgens and estrogens “result in an impaired sperm production,” testicular volume diminishes, and while spermatogenesis “might resume after discontinuation of prolonged treatment,” the data are limited.

The clearest picture of what long-term hormones do comes from tissue removed at surgery. Jindarak and colleagues reviewed 173 orchiectomy specimens from trans women who had gender-affirming surgery at a Bangkok hospital between 2000 and 2015, after a mean of about 8.5 years of hormone use (hormones were stopped 4 weeks before surgery). Normal spermatogenesis was present in 11% of specimens; the rest showed maturation arrest (36.4%), hypospermatogenesis (26%), Sertoli cell-only pattern (20.2%) or seminiferous tubule hyalinization (6.4%). Severity was not associated with the duration of therapy (P = 0.81). The authors conclude that gamete preservation should be offered before starting hormonal treatment.

There is a second reason not to wait. Even before any hormones, semen parameters in trans women may be lower than in cisgender men. In a 2019 pilot case-control study (Marsh et al.), 22 trans women seeking fertility preservation before starting hormones were compared with 17 cisgender men who had fathered a child within the previous two years; none of the participants had used hormones in the previous 18 months. Median sperm concentration was 31.89 versus 54.6 million per mL, total motile sperm 27.63 versus 106.6 million, and 3 of the 22 samples contained no sperm. The authors still concluded that cryopreservation before hormone therapy is a viable option for most trans women. WPATH notes that wearing the genitals tight against the body, for example with tight undergarments for tucking, may also affect semen quality, so it is worth asking the clinic whether to change anything in the weeks before collection.

What the guidelines say

Three widely used guidelines agree on the principle.

• WPATH Standards of Care, Version 8 (2022). Statement 16.1 recommends that clinicians prescribing or referring for hormones or surgery advise patients about known effects on future fertility, “potential effects of therapies that are not well studied and are of unknown reversibility,” fertility preservation options, and the psychosocial implications of infertility. Statement 16.3 recommends that transgender care teams partner with reproductive specialists to provide information and fertility preservation services before medical and surgical interventions that may affect fertility; the supporting text says sperm cryopreservation is an established technique that can be offered “preferably prior to the initiation of GAHT.” SOC8 also acknowledges that cost, access and the discomfort of the procedures are real barriers, and that many people worry about postponing transition.
• Endocrine Society clinical practice guideline (Hembree et al., 2017). Recommendation 1.5 says clinicians should “inform and counsel all individuals seeking gender-affirming medical treatment regarding options for fertility preservation” before puberty suppression and before hormonal therapy of the affirmed gender, in adolescents and adults.
• UCSF Transgender Care guidelines (2016). The fertility chapter says prolonged estrogen exposure of the testes has been associated with testicular damage, that restoration of spermatogenesis after extended estrogen treatment has not been well studied, and that cryopreservation of sperm before hormone therapy is the most successful fertility preservation option for trans women.

In all three, fertility preservation is something to be offered and discussed, not a condition of care; choosing not to bank is a legitimate decision. If you are undecided, note that clinics typically space collections at least 2 days apart, so the sperm cryopreservation process can often fit into a short window before a planned hormone start.

Can sperm production come back if you pause hormones?

This is the question most people ask after they have already started, and the honest answer is: sometimes, slowly, and not predictably. The most detailed data come from de Nie and colleagues (Cell Reports Medicine, 2023), who followed nine trans women who stopped gender-affirming hormones, four to conceive with a partner and five to bank sperm. They had been on hormones for a median of 36 months (range 6 to 216 months).

In that series, three participants had no sperm on their first test; two later produced sperm at 8 and 10 months, and the third had testicular sperm extraction at 17 months, which recovered mature sperm. Three partners conceived naturally, at 4, 20 and 40 months after cessation. The authors are candid about the limits: nine people, no semen data from before or during hormones, and inconsistent hormone monitoring. They describe their findings as preliminary evidence that the effect of hormones on sperm production can be reversed, and call for larger studies. UCSF Transgender Care’s 2016 guideline says that, anecdotally, return of fertility can take 3 to 6 months, though some people experience permanent loss of fertility or need assisted reproduction.

Pausing has two costs that are easy to underestimate. Testosterone returns, with the physical and emotional effects hormones were suppressing; WPATH, discussing the return of sperm production after GnRH agonists, notes that “the psychological burden of re-exposure to testosterone should be considered.” And the timing is unpredictable: in the de Nie series there was no obvious relationship between how long someone had taken hormones and when sperm was first found. Anyone considering a pause can ask a fertility specialist and their prescribing clinician about a baseline semen analysis and a plan first.

After orchiectomy, which vaginoplasty usually includes, the question becomes moot: the testes are gone. The only remaining routes are sperm banked earlier or sperm or testicular tissue retrieved and frozen at the time of surgery, which has to be arranged with an andrology laboratory in advance. SOC8 says the possibility of storing gonadal tissue should be discussed before any genital surgery that would result in sterilization, and that the likelihood of being able to use that tissue must be clearly addressed, so it is worth raising early with your surgical team if you have not banked.

Producing a sample when the process itself is distressing

Standard sperm banking needs an ejaculated semen sample, and for many trans women and non-binary people that is the hardest part, not the cost. Clinics that work with cancer patients have long dealt with people who cannot produce a sample on demand, and the same accommodations apply to you. It helps to ask about them before you book rather than on the day.

• Collect at home. Cancer Research UK notes that you may be able to bring a sample from home, usually within 1 hour of producing it, in a special condom or pot the clinic provides. Not every clinic allows this, so ask.
• Use a mail-in service (US only). Legacy, for example, ships a collection kit to your home and you return it overnight with a prepaid label; the company states that it has helped more than 2,000 transitioning people and that its care team has been trained by Folx. Our at-home sperm freezing kit comparison shows what each service includes.
• Private room on site. If you collect at the clinic you will be shown into a private room. Ask whether a partner may accompany you, and whether forms and sample labels can carry your name and pronouns.
• If ejaculation is not possible. Cancer Research UK describes two alternatives: sperm aspiration from the testis with a needle under local anesthetic, or removal of a small amount of testicular tissue under general anesthetic. A urologist or fertility specialist can explain whether either fits your situation.

Cancer Research UK suggests 3 or 4 days without ejaculation before each sample; your clinic will give its own window. Before banking, clinics also run blood tests, which Cancer Research UK says include HIV, hepatitis B and hepatitis C.

How many samples to freeze

Cancer Research UK says most clinics recommend at least 2 samples and if possible 3, with at least 2 days between collections. Because the Marsh study found lower concentrations and total motile counts in trans women even before hormones, your clinic may suggest an extra sample or divide each one into more straws. The number also depends on how the sperm might be used later: intracytoplasmic sperm injection (ICSI) needs very few sperm per attempt, while intrauterine insemination (IUI) needs far more. Our guide on how many samples to freeze walks through the arithmetic. If you are starting hormones soon, tell the clinic your target date so collections can be scheduled around it.

What it costs and where to find lower-cost options

The prices below are US list prices checked on 19 October 2026. Every provider adds annual storage, so the first-year figure is only part of the picture; the sperm freezing cost calculator models samples times years for different providers.

Legacy’s services are available only within the United States, and Fairfax notes that its fees are subject to change without notice. For clinic prices elsewhere and local funding rules, see our cost by country tables and the United States cost page.

Point of Pride’s Thrive Fund deserves a closer look if money is the barrier. It covers gender-affirming needs not handled by the organization’s other programs, with “fertility preservation or reproductive health services” explicitly listed. Applicants must identify as transgender and have financial need, and for most types of support must be 18 or older or have a parent’s or guardian’s permission; funds are usually paid directly to the provider. The fund reports over $117,000 awarded to 105 recipients (as of October 2026). Applications are accepted only from 1 to 31 August, so plan ahead.

Insurance in the United States

RESOLVE lists 22 states with laws requiring some coverage of fertility preservation for iatrogenic infertility, which several of those laws define as “an impairment of fertility caused directly or indirectly by surgery, chemotherapy, radiation, or other medical treatment.” On paper, gender-affirming hormone therapy or orchiectomy could fit “other medical treatment,” but the RESOLVE list does not say whether gender-affirming treatment qualifies, and several states narrow coverage to cancer or specific diagnoses, including Florida, Georgia, Nevada, Oklahoma and Utah’s Medicaid program.

The fine print matters as much as the headline. A 2021 analysis in JAMA Health Forum (Flores Ortega et al.) of 11 mandate states found that sperm cryopreservation was explicitly covered in 6 (Delaware, Illinois, Maryland, New Hampshire, New York and Utah), but storage was specified as covered in only 4 (Delaware, Illinois, New York and Utah) and explicitly excluded in Connecticut, Maryland and New Jersey. That study did not analyze gender-affirming care either. It is worth asking your insurer in writing whether fertility preservation before gender-affirming hormone therapy is covered, what documentation the prescribing clinician must provide, and whether storage is included. Our guide to sperm freezing insurance coverage explains the state-by-state picture.

Questions to ask before you book

A short phone call will tell you whether a clinic is a good fit. Our questions to ask your clinic checklist covers the general points; for gender-affirming care, add these:

• Can I produce the sample at home, and how quickly must it reach you? May a partner come with me?
• Will my name and pronouns be used on forms and labels, and do you have experience with trans and non-binary patients?
• How many samples and straws do you recommend, what is the annual storage fee, and what happens if I miss a payment?
• If I later have an orchiectomy, can you coordinate sperm or tissue retrieval with the surgical team?

This guide is general information, not medical advice. Decisions about whether to bank, whether to pause hormones, and how to time collection around your transition belong in a conversation with your gender-affirming care provider and a fertility specialist who knows your history.